BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 8642632)

  • 1. Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.
    Gall J; Kass-Eisler A; Leinwand L; Falck-Pedersen E
    J Virol; 1996 Apr; 70(4):2116-23. PubMed ID: 8642632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependence of adenovirus infectivity on length of the fiber shaft domain.
    Shayakhmetov DM; Lieber A
    J Virol; 2000 Nov; 74(22):10274-86. PubMed ID: 11044071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.
    Stevenson SC; Rollence M; Marshall-Neff J; McClelland A
    J Virol; 1997 Jun; 71(6):4782-90. PubMed ID: 9151872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
    Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
    J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain.
    Stevenson SC; Rollence M; White B; Weaver L; McClelland A
    J Virol; 1995 May; 69(5):2850-7. PubMed ID: 7707507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus type 9 fiber knob binds to the coxsackie B virus-adenovirus receptor (CAR) with lower affinity than fiber knobs of other CAR-binding adenovirus serotypes.
    Kirby I; Lord R; Davison E; Wickham TJ; Roelvink PW; Kovesdi I; Sutton BJ; Santis G
    J Virol; 2001 Aug; 75(15):7210-4. PubMed ID: 11435605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.
    Gall JG; Crystal RG; Falck-Pedersen E
    J Virol; 1998 Dec; 72(12):10260-4. PubMed ID: 9811772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.
    Stepanenko AA; Chekhonin VP
    Virus Res; 2018 Sep; 257():40-51. PubMed ID: 30125593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism.
    Takayama K; Reynolds PN; Short JJ; Kawakami Y; Adachi Y; Glasgow JN; Rots MG; Krasnykh V; Douglas JT; Curiel DT
    Virology; 2003 May; 309(2):282-93. PubMed ID: 12758175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abolition of hCAR-dependent cell tropism using fiber knobs of Atadenovirus serotypes.
    Renaut L; Colin M; Leite JP; Benko M; D'Halluin JC
    Virology; 2004 Apr; 321(2):189-204. PubMed ID: 15051380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
    Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
    Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flexibility of the adenovirus fiber is required for efficient receptor interaction.
    Wu E; Pache L; Von Seggern DJ; Mullen TM; Mikyas Y; Stewart PL; Nemerow GR
    J Virol; 2003 Jul; 77(13):7225-35. PubMed ID: 12805421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors.
    Borovjagin AV; Krendelchtchikov A; Ramesh N; Yu DC; Douglas JT; Curiel DT
    Cancer Gene Ther; 2005 May; 12(5):475-86. PubMed ID: 15706356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor binding sites and antigenic epitopes on the fiber knob of human adenovirus serotype 3.
    Liebermann H; Mentel R; Bauer U; Pring-Akerblom P; Dölling R; Modrow S; Seidel W
    J Virol; 1998 Nov; 72(11):9121-30. PubMed ID: 9765458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus serotype 30 fiber does not mediate transduction via the coxsackie-adenovirus receptor.
    Law LK; Davidson BL
    J Virol; 2002 Jan; 76(2):656-61. PubMed ID: 11752156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactive domains and integrin-binding motifs in adenovirus penton base capsomer.
    Hong SS; Bardy M; Monteil M; Gay B; Denesvre C; Tournier J; Martin G; Eloit M; Boulanger P
    Viral Immunol; 2000; 13(3):353-71. PubMed ID: 11016599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini.
    Xie J; Chiang L; Contreras J; Wu K; Garner JA; Medina-Kauwe L; Hamm-Alvarez SF
    J Virol; 2006 Dec; 80(23):11833-51. PubMed ID: 16987972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber.
    Nakamura T; Sato K; Hamada H
    J Virol; 2003 Feb; 77(4):2512-21. PubMed ID: 12551989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudopackaging of adenovirus type 5 genomes into capsids containing the hexon proteins of adenovirus serotypes B, D, or E.
    Ostapchuk P; Hearing P
    J Virol; 2001 Jan; 75(1):45-51. PubMed ID: 11119572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys.
    Nanda A; Lynch DM; Goudsmit J; Lemckert AA; Ewald BA; Sumida SM; Truitt DM; Abbink P; Kishko MG; Gorgone DA; Lifton MA; Shen L; Carville A; Mansfield KG; Havenga MJ; Barouch DH
    J Virol; 2005 Nov; 79(22):14161-8. PubMed ID: 16254351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.